ANACOR PHARMACEUTICALS INC Inactive Instrument
Anacor Pharmaceuticals Inc Share Price
Equities
US0324201013
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2016 | Anacor Pharmaceuticals : received rival bid before Pfizer deal - filing | RE |
| 2016 | Anacor Pharmaceuticals : Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel | RE |
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 24/16/24 |
| Chief Tech/Sci/R&D Officer | 77 | 01/04/01 | |
| Director/Board Member | - | 24/16/24 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Douglas Giordano
CEO | Chief Executive Officer | 61 | 24/16/24 |
Bryan Supran
BRD | Director/Board Member | - | 24/16/24 |
| Director/Board Member | - | 24/16/24 |
| 1st Jan change | Capi. | |
|---|---|---|
| +1.77% | 42.86B | |
| +45.49% | 41.36B | |
| +12.24% | 42.74B | |
| -8.83% | 27.68B | |
| +7.44% | 25.15B | |
| -23.01% | 18.63B | |
| +30.56% | 12.37B | |
| -1.82% | 11.92B | |
| +8.35% | 11.21B |
- Stock Market
- Equities
- Stock
